Evidence map›Paper›PMID 34111862›Full record

ArticleBiofabrication2021

Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells.

Norman M Drzeniek, Andrea Mazzocchi, Stephan Schlickeiser, Steven D Forsythe, Guido Moll, Sven Geißler, Petra Reinke, Manfred Gossen, Vijay S Gorantla, Hans-Dieter Volk and 1 more

Open access · hybridFull text read
In one paragraph

Article in Biofabrication, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Engineered organoids for biomedical applications.Advanced drug delivery reviews · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Norman M DrzeniekBerlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0001-6562-2351
Andrea MazzocchiKnown Medicine Inc., 675 Arapeen Dr, Suite 103A-1, Salt Lake City, UT 84108, United States of America.ORCID 0000-0002-5534-9678
Stephan SchlickeiserBerlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0003-3142-2890
Steven D ForsytheWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, United States of America.ORCID 0000-0003-4099-6642
Guido MollBerlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0001-6173-5957
Sven GeißlerBerlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0002-8750-6324
Petra ReinkeBerlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0003-0771-4375
Manfred GossenBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Campus Virchow-Klinikum, Augustenburger Platz 1, Berlin 13353, Germany.ORCID 0000-0002-1761-4063
Vijay S GorantlaWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, United States of America.ORCID 0000-0003-0686-059X
Hans-Dieter VolkBerlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0002-7743-6668
Shay SokerWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, United States of America.ORCID 0000-0002-8458-9232
Forest Institute · USBerlin-Brandenburger Centrum für Regenerative Therapien · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEHumboldt-Universität zu Berlin · DE

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Translational Oncology Training ProgramT32CA247819 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PARDEE, TIMOTHY SEBASTIAN, WATABE, KOUNOSUKE · 2020 to 2024
$1.4M
NCI NIH HHS P30 CA012197NCI NIH HHS T32 CA247819
6 · The paper itself

Abstract

The therapeutic efficacy of clinically applied mesenchymal stromal cells (MSCs) is limited due to their injection into harsh

Indexed as

Mesenchymal Stem CellsCollagen Type IEndothelial CellsHumansHyaluronic AcidHydrogelsCollagen Type IHyaluronic AcidHydrogels3D cultureangiogenesisbiochemical cuesbiointerfacebiomaterialbiomedical engineeringcell deliverycell-material interactionscollagenhyaluronic acidinjectable hydrogelmaterial structuremesenchymal stromal cells (MSCs)regenerative medicinesecretometissue engineering

Identifiers

PMID34111862
PMCPMC10024818
OpenAlexW3166563530

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read26
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.